Results 261 to 270 of about 46,900 (298)

Effect of dipeptidyl peptidase‐4 inhibitors on complement activation

Diabetes/Metabolism Research and Reviews, 2020
AbstractBackgroundAdverse activation of the complement cascade in the innate immune system appears to be involved in development of vascular complications in diabetes. Dipeptidyl peptidase‐4 (DPP‐4) is a cell surface serine protease expressed in a variety of tissues.
Ingeborg T. Hoffmann‐Petersen, Charlotte B. Holt, Lisbeth Jensen, Camilla Hage, Linda G. Mellbin, Steffen Thiel, Troels K. Hansen, Jakob A. Østergaard   +7 more
openaire   +3 more sources

Dipeptidyl peptidase-4 inhibition and renoprotection

Current Opinion in Nephrology and Hypertension, 2017
This article analyzes the potential beneficial effects of dipeptidyl peptidase (DPP)-4 inhibitors on renal diseases.The pathological significance of DPP-4, either dependent or independent on catalytic activities, on renal diseases has been reported in preclinical studies.
Yuta, Takagaki, Daisuke, Koya, Keizo, Kanasaki   +2 more
openaire   +2 more sources

Dipeptidyl peptidase-4 inhibitors

2016
Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
openaire   +1 more source

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Highlights: Introduction Pharmacology Treatment Advantages/Disadvantages Therapeutic Considerations Monographs ...
Kimberly C. McKeirnan, Joshua J. Neumiller   +1 more
openaire   +2 more sources

Dipeptidyl-peptidase-4-inhibitors

Reactions Weekly, 2023
openaire   +1 more source

Dipeptidyl Peptidase-4 – A Comprehensive Review

Current Enzyme Inhibition
Type 2 diabetes mellitus is a growing global public health issue, with its prevalence projected to increase in the coming decades. It is one of the most prevalent and growing global health concerns, affecting millions of individuals worldwide. The condition is classified into two primary types: Type 1 diabetes,
Venkatesan Parthasarathi, Hemalatha Kanagarajan   +1 more
openaire   +1 more source

Periostin and Dipeptidyl Peptidase-4

Immunology and Allergy Clinics of North America, 2018
Claire Emson, Tuyet-Hang Pham, Scott Manetz, Paul Newbold   +3 more
openaire   +1 more source

Dipeptidyl Peptidase-4

RCSB Protein Data Bank, 2016
openaire   +2 more sources

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source